Compound Detail
CHEMBL4462284
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4462284 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XOCORAKOJNJNNN-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
443.5
MW (Da)
3.01
ALogP
5
HBA
3
HBD
88.0
PSA (Ų)
0.32
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.0
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 10.0 | nM | 8.0 | Cytotoxicity against human HepG2 cells incubated for 48 hrs by sulforhodamine B ... | 31401008 |
| Ehrlich | IC50 | = | 20.0 | nM | 7.7 | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse asses... | 31401008 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31401008 | 10.1016/j.bmc.2019.07.050 | Ehrlich | 1 |
| 31401008 | 10.1016/j.bmc.2019.07.050 | HepG2 | 1 |
| 33129590 | 10.1016/j.ejmech.2020.112946 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine